GB1381872A - Pharmaceutical compositions for inhalation - Google Patents

Pharmaceutical compositions for inhalation

Info

Publication number
GB1381872A
GB1381872A GB2920771A GB2920771A GB1381872A GB 1381872 A GB1381872 A GB 1381872A GB 2920771 A GB2920771 A GB 2920771A GB 2920771 A GB2920771 A GB 2920771A GB 1381872 A GB1381872 A GB 1381872A
Authority
GB
United Kingdom
Prior art keywords
inhalation
microns
june
particle size
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2920771A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB2920771A priority Critical patent/GB1381872A/en
Publication of GB1381872A publication Critical patent/GB1381872A/en
Application status is Expired legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Abstract

1381872 Compositions for inhalation FISONS Ltd 1 June 1972 [22 June 1971] 29207/71 Heading A5B A pharmaceutical powder composition comprises a mixture of a solid inhalation medicament having an effective particle size, (as defined), in the range 0.01 to 10 microns, and a solid carrier acceptable in the lungs, having an effective particle size in the range of from 80 to 150 microns. Suitable medicaments include the di-sodium salt of 5, 5'-[(5, 5'-(2-hydroxytrimethylene) dioxy) bis (4-oxo-4H-1-benzopyran-2-yl)] tetrazole, sodium cromoglycate, isoprenaline, ephedrine, adrenaline, theophylline, tetracycline, steroids, enzymes, vitamins, antihistamines, N-acetyl cysteine or its salts, propyliodone, tantalum and paracetamol. The carrier may be coated with a material such as stearic acid or polyvinyl pyrrolidone which may give a sustained release action to the medicament.
GB2920771A 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation Expired GB1381872A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB2920771A GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation
ZA723999A ZA7203999B (en) 1971-06-22 1972-06-12 Pharmaceutical powder composition suitable for inhalation
CA144,512A CA970685A (en) 1971-06-22 1972-06-13 Composition containing inhalation medicaments
NL7208207A NL176743C (en) 1971-06-22 1972-06-15 Improvement of the method according to Patent Specification No. 161984 for the preparation of a pharmaceutical powder form inhaleerpreparaat, as well as a container which contains such a composition.
DE19722229981 DE2229981C3 (en) 1971-06-22 1972-06-20
DK309072A DK134970C (en) 1971-06-22 1972-06-21
FR7222310A FR2143163B2 (en) 1971-06-22 1972-06-21
AU43805/72A AU462722B2 (en) 1971-06-22 1972-06-22 Pharmaceutical powder composition for inhalation
JP5040373A JPS5046820A (en) 1971-06-22 1973-05-08

Publications (1)

Publication Number Publication Date
GB1381872A true GB1381872A (en) 1975-01-29

Family

ID=10287853

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2920771A Expired GB1381872A (en) 1971-06-22 1971-06-22 Pharmaceutical compositions for inhalation

Country Status (9)

Country Link
JP (1) JPS5046820A (en)
AU (1) AU462722B2 (en)
CA (1) CA970685A (en)
DE (1) DE2229981C3 (en)
DK (1) DK134970C (en)
FR (1) FR2143163B2 (en)
GB (1) GB1381872A (en)
NL (1) NL176743C (en)
ZA (1) ZA7203999B (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067130A2 (en) * 1981-06-04 1982-12-15 LABORATORIO FARMACEUTICO LOFARMA S.a.s. An allergen dry powder composition and process for its preparation
US4515805A (en) * 1980-11-05 1985-05-07 Fisons Plc Soluble sodium cromoglycate compositions
US6153224A (en) * 1995-01-31 2000-11-28 Co-Ordinated Drug Development Limited Carrier particles for use in dry powder inhalers
US6183782B1 (en) 1994-03-15 2001-02-06 Glaxo Group Limited Inhalation composition containing lactose pellets
WO2001026630A1 (en) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
US6221338B1 (en) 1993-10-26 2001-04-24 Vectura Limited Method of producing particles for use in dry powder inhalers
US6284287B1 (en) 1994-07-16 2001-09-04 Asta Medica Ag Particulate formulation for administration by inhalation
US6475523B1 (en) 1995-07-24 2002-11-05 Vectura Limited Powders comprising anti-adherant materials for use in dry powder inhalers
US6884794B2 (en) 2000-04-17 2005-04-26 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
WO2005046586A2 (en) 2003-11-04 2005-05-26 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
WO2005104745A2 (en) 2004-04-27 2005-11-10 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
US7399528B2 (en) 1999-07-16 2008-07-15 Chiesi Farmaceutici S.P.A. Powder particles with smooth surface for use in inhalation therapy
US7541022B2 (en) 2000-04-17 2009-06-02 Vectura Limited Pharmaceutical formulations for dry powder inhalers
EP2283817B1 (en) 2000-11-30 2016-05-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
US9365905B2 (en) 2005-02-10 2016-06-14 Dmv-Fonterra Excipients Technology Gmbh Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
US10238601B2 (en) 2000-11-30 2019-03-26 Vectura Limited Particles for use in a pharmaceutical composition

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2332663C2 (en) * 1973-06-23 1986-07-31 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
JPS6034925B2 (en) * 1979-07-31 1985-08-12 Teijin Ltd
JPS6237016B2 (en) * 1983-03-09 1987-08-10 Teijin Ltd
DE3688617T2 (en) * 1986-11-03 1993-11-18 Allen W Jacobs A method for blending a solid particulate component in aerosol preparations for inhalation of nicotine.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122284A (en) * 1965-03-19 1968-08-07 Fisons Pharmaceuticals Ltd Inhalation device
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515805A (en) * 1980-11-05 1985-05-07 Fisons Plc Soluble sodium cromoglycate compositions
EP0067130A2 (en) * 1981-06-04 1982-12-15 LABORATORIO FARMACEUTICO LOFARMA S.a.s. An allergen dry powder composition and process for its preparation
FR2512670A1 (en) * 1981-06-04 1983-03-18 Lofarma Farma Lab Capsules containing the active ingredient of an allergen and process for their preparation
EP0067130A3 (en) * 1981-06-04 1984-01-11 Lofarma Farma Lab Capsules containing the active principle of an allergen, and process for their preparation
US8137657B2 (en) 1993-10-26 2012-03-20 Vectura Limited Carrier particles for use in dry powder inhalers
US6582678B2 (en) 1993-10-26 2003-06-24 Vectura Limited Carrier particles for use in dry powder inhalers
US6221338B1 (en) 1993-10-26 2001-04-24 Vectura Limited Method of producing particles for use in dry powder inhalers
US6183782B1 (en) 1994-03-15 2001-02-06 Glaxo Group Limited Inhalation composition containing lactose pellets
US6955824B1 (en) 1994-03-15 2005-10-18 Glaxo Group Limited Inhalation composition containing lactose pellets
US6284287B1 (en) 1994-07-16 2001-09-04 Asta Medica Ag Particulate formulation for administration by inhalation
US7011818B2 (en) 1995-01-31 2006-03-14 Vectura Limited Carrier particles for use in dry powder inhalers
US7718163B2 (en) 1995-01-31 2010-05-18 Vectura Limited (01696917) Carrier particles for use in dry powder inhalers
US6153224A (en) * 1995-01-31 2000-11-28 Co-Ordinated Drug Development Limited Carrier particles for use in dry powder inhalers
US8920781B2 (en) 1995-01-31 2014-12-30 Vectura Limited Carrier particles for use in dry powder inhalers
US6475523B1 (en) 1995-07-24 2002-11-05 Vectura Limited Powders comprising anti-adherant materials for use in dry powder inhalers
US7399528B2 (en) 1999-07-16 2008-07-15 Chiesi Farmaceutici S.P.A. Powder particles with smooth surface for use in inhalation therapy
WO2001026630A1 (en) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
US7022311B1 (en) 1999-10-12 2006-04-04 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
US9566239B2 (en) 2000-04-17 2017-02-14 Vectura Limited Pharmaceutical formulations for dry powder inhalers
US7223748B2 (en) 2000-04-17 2007-05-29 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
US7541022B2 (en) 2000-04-17 2009-06-02 Vectura Limited Pharmaceutical formulations for dry powder inhalers
US6884794B2 (en) 2000-04-17 2005-04-26 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
EP2272508A2 (en) 2000-04-17 2011-01-12 Vectura Limited Pharmaceutical Formulations for Dry Powder Inhalers
US8871274B2 (en) 2000-04-17 2014-10-28 Vectura Limited Pharmaceutical formulations for dry powder inhalers
EP1719505A2 (en) 2000-04-17 2006-11-08 CHIESI FARMACEUTICI S.p.A. Pharmaceutical formulations for dry powder inhalers in the form of hard pellets
US9962338B2 (en) 2000-11-30 2018-05-08 Vectura Limited Method of making particles for use in a pharmaceutical composition
US10188612B2 (en) 2000-11-30 2019-01-29 Vectura Limited Pharmaceutical compositions for inhalation
EP2283817B1 (en) 2000-11-30 2016-05-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
US9931304B2 (en) 2000-11-30 2018-04-03 Vectura Limited Method of making particles for use in a pharmaceutical composition
US10238601B2 (en) 2000-11-30 2019-03-26 Vectura Limited Particles for use in a pharmaceutical composition
WO2005046586A2 (en) 2003-11-04 2005-05-26 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
EP2570128A1 (en) 2004-04-27 2013-03-20 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
WO2005104745A2 (en) 2004-04-27 2005-11-10 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
US9365905B2 (en) 2005-02-10 2016-06-14 Dmv-Fonterra Excipients Technology Gmbh Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom

Also Published As

Publication number Publication date
DE2229981C3 (en) 1981-04-02
NL176743C (en) 1985-06-03
AU4380572A (en) 1974-01-03
AU462722B2 (en) 1975-07-03
NL176743B (en) 1985-01-02
CA970685A1 (en)
CA970685A (en) 1975-07-08
NL7208207A (en) 1972-12-28
FR2143163B2 (en) 1975-10-31
FR2143163A2 (en) 1973-02-02
DE2229981A1 (en) 1972-12-28
ZA7203999B (en) 1973-06-27
DK134970B (en) 1977-02-21
DE2229981B2 (en) 1980-07-03
DK134970C (en) 1977-07-18
JPS5046820A (en) 1975-04-25

Similar Documents

Publication Publication Date Title
US3429308A (en) Method for administering drugs from a vehicle adhering by suction to the parabuccal cavity mucous membrane
US3427378A (en) Sustained release encapsulated formula
US3598122A (en) Bandage for administering drugs
DE3268533D1 (en) Inhalation drugs, methods for their production and pharmaceutical formulations containing them
AU564536B2 (en) Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
TWI280141B (en) Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
SE7502725L (en)
SE8207167D0 (en) Method for the front tell up of therapeutic compounds with forlengd tripping based on hydroxypropyl methylcellulose
PT67292A (en) Process for the preparation of a nasal and pulmonary pharmaceutical composition and its forms of administration
CA2455115A1 (en) Pharmaceutical aerosol formulation
ES2171991T3 (en) galenic form of prolonged release of milnacipran.
MY121073A (en) Pharmaceutical formulations for aerosols with two or more active substances
JPH02108636A (en) Antitumor combined pharmaceutical preparation
EP0254067A3 (en) Composition for metastasis prevention
BR0016085A (en) release device, inhaler, and methods of administration of a dry powdered medicament, and in the treatment of a patient with a bronchial disorder.
SE8005499L (en) Chewing gum capable of delivering atomised vattenolosligt materials
FR2285857B1 (en)
CA2153326A1 (en) Taxane formulations comprising phospholipids
ES2124794T3 (en) Process for producing fine granules.
GR1000357B (en) Process for the preparation of a composition
NZ502228A (en) Multiparticulate tablet with fast rate of disintegration
CA2352483A1 (en) Pharmaceutical aerosol composition containing hfa 227 and hfa 134a
GB1517480A (en) Opiate analgesic formulation with a low potential for abuse
EP0951917A3 (en) Particle delivery of particularly a powdered therapeutical agent
HK19180A (en) Azolyl-(1)-methanes and their salts,processes for their preparation and their use as medicaments

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee